Heart Doc VIP with Dr. Joel Kahn
Heart Doc VIP with Dr. Joel Kahn
Episode 463: Three Ways to Cleanse Your Blood
Loading
/

Episode 463: Three Ways to Cleanse Your Blood

This week, Dr. Joel Kahn explores three advanced methods for cleansing the blood. He begins with apheresis, a medical technique that removes LDL cholesterol and Lipoprotein(a), and discusses new developments in access to this life-saving therapy. Dr. Kahn also breaks down two emerging treatments gaining popularity—EBOO (Extracorporeal Blood Oxygenation and Ozonation) and TPE (Therapeutic Plasma Exchange)—and how they may play a role in improving cardiovascular health.

In the second half, Dr. Kahn turns to the topic of cholesterol-lowering therapies like statins, emphasizing how long-term use and individualized risk assessment matter more than online debates suggest. He highlights tools such as the Mayo Clinic Statin Decision Aid, PREVENT calculator, and Astro-CHARM calculator to help patients and practitioners make informed decisions. 

Thanks to the Fresh Pressed Olive Oil Club for sponsoring this episode. Visit getfreshdrkahn.com for a special offer.

More From Current Show

This week, Dr. Kahn presents the case of a patient seen this month at the Kahn Center for...
Listen Now
This week, Dr. Kahn presents a new scientific statement by the American College of Cardiology on nutrition to...
Listen Now
This week, as a bonus, Dr. Kahn interviews a Detroit clothing legend, Phil, who celebrated his 100th birthday...
Listen Now
This week, Dr. Kahn brings back the topic of Mankai Duckweed, the smallest edible plant, which provides a...
Listen Now
In this episode, Dr. Kahn interviews Ben Tammetta, founder of H2Biohacker, about inhaled molecular hydrogen. They discuss the...
Listen Now
This week, Dr. Kahn discusses a large study on the impact of whole-grain consumption on heart health. The...
Listen Now
This week, Dr. Kahn discusses two large new studies examining the role of routine coronary artery calcium CT...
Listen Now
This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a...
Listen Now

Related Episodes

No related episodes found.